Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Electroporation therapy may enhance the ability of chemotherapy
drugs to enter tumor cells. Combining chemotherapy with electroporation therapy may kill more
tumor cells.
PURPOSE: Phase I trial to study the effectiveness of electroporation therapy and bleomycin in
treating patients who have locally advanced pancreatic cancer.